ADAP
#6356
Adaptimmune Therapeutics plc - American Depositary Shares
0.0 5 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-61.54%
6 month change
-81.48%
Year Change
-28.57%
Previous Close
0.0 6
Open
0.0 7
Low
0.0 5
High
0.0 7
Volume
13.67 K
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5312 |  NVO Novo Nordisk A/S | 45.72 USD | -1.17% | -2.74% | -10.37% | -18.44% | 0 USD | ||
| 5527 |  CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1198 USD | 0.00% | +9.31% | +30.08% | +207.97% | 0 USD | ||
| 6359 |  AADI Aadi Bioscience Inc | 2.05 USD | 0.00% | 0.00% | -19.29% | -27.30% | 0 USD | ||
| 6491 |  RVMDW Revolution Medicines, Inc. - Warrant | 11.5800 USD | -12.67% | -0.17% | +32.19% | +6517.14% | 44.22 B USD |
Frequently asked questions about Adaptimmune Therapeutics PLC
What is the Adaptimmune Therapeutics PLC stock price today?
The current price of Adaptimmune Therapeutics PLC (ADAP) is 0.05. Over the past 24 hours, the stock has changed by 0.00%. Follow the ADAP chart for real-time price dynamics.
What is the stock ticker of Adaptimmune Therapeutics PLC?
Adaptimmune Therapeutics PLC trades under the ticker ADAP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
What is the market capitalization of Adaptimmune Therapeutics PLC?
Adaptimmune Therapeutics PLC currently has a market capitalization of 0. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
How many employees does Adaptimmune Therapeutics PLC have?
As of the latest available data, Adaptimmune Therapeutics PLC has 506 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Adaptimmune Therapeutics PLC stock?
You can buy Adaptimmune Therapeutics PLC (ADAP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Adaptimmune Therapeutics PLC stock?
Investing in Adaptimmune Therapeutics PLC requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADAP chart and related analysis on metatrader.com as part of your research.